Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-04-01

Clinical Trial Update: Extracorporeal CO2 Removal for Acute Decompensation of COPD [NA]

View source ↗

Summary

The clinical trial evaluating extracorporeal CO2 removal for acute decompensation of chronic obstructive pulmonary disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Bologna | Conditions: Pulmonary Disease, Chronic Obstructive | NA | Status: WITHDRAWN